Producing recombinant adeno-associated virus in foster cells: Overcoming production limitations using a baculovirus-insect cell expression strategy

Human Gene Therapy

Volumn 20, Issue 8, 2009, Pages 807-817

  Virag, Tamas ^a   Cecchini, Sylvain ^a   Kotin, Robert M ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; MESSENGER RNA; PARVOVIRUS VECTOR; STRUCTURAL PROTEIN; VIRUS DNA; WART VIRUS VACCINE;

ADENO ASSOCIATED VIRUS; BACULOVIRUS EXPRESSION SYSTEM; CODON; DOWNSTREAM PROCESSING; GENE THERAPY; LEPIDOPTERA; NONHUMAN; OPEN READING FRAME; REVIEW; VIRUS RECOMBINANT;

ANIMALS; BACULOVIRIDAE; DEPENDOVIRUS; GENETIC TECHNIQUES; GENETIC VECTORS; INSECTS; VIRAL PROTEINS;

ADENO-ASSOCIATED VIRUS; HEXAPODA;

EID: 68949220858     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.092     Document Type: Review

References (60)

1. Abmayr, S., Gregorevic, P., Allen, J.M., and Chamberlain, J.S. (2005). Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery. Mol. Ther. 12, 441-450.
2. Agbandje, M., McKenna, R., Rossmann, M.G., Strassheim, M.L., and Parrish, C.R. (1993). Structure determination of feline panleukopenia virus empty particles. Proteins 16, 155-171.
3. Allen, J.M., Halbert, C.L., and Miller, A.D. (2000). Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6. Mol. Ther. 1, 88-95.
4. Aslanidi, G., Lamb, K., and Zolotukhin, S. (2009). An inducible system for highly efficient production of recombinant adeno-associated virus (rAAV) vectors in insect Sf9 cells. Proc. Natl. Acad. Sci. U.S.A. 106, 5059-5064.
5. Athanasopoulos, T., Graham, I.R., Foster, H., and Dickson, G. (2004). Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD). Gene Ther. 11(Suppl. 1), S109-S121.
6. Becerra, S.P., Rose, J.A., Hardy, M., Baroudy, B.M., and Anderson, C.W. (1985). Direct mapping of adeno-associated virus capsid proteins B and C: A possible ACG initiation codon. Proc. Natl. Acad. Sci. U.S.A. 82, 7919-7923.
7. Becerra, S.P., Koczot, F., Fabisch, P., and Rose, J.A. (1988). Synthesis of adeno-associated virus structural proteins requires both alternative mRNA splicing and alternative initiations from a single transcript. J. Virol. 62, 2745-2754.
8. Berkower, I., Raymond, M., Muller, J., Spadaccini, A., and Aberdeen, A. (2004). Assembly, structure, and antigenic properties of virus-like particles rich in HIV-1 envelope gp120. Virology 321, 75-86.
9. Bishop, B., Dasgupta, J., Klein, M., Garcea, R.L., Christensen, N.D., Zhao, R., and Chen, X.S. (2007). Crystal structures of four types of human papillomavirus L1 capsid proteins: Understanding the specificity of neutralizing monoclonal antibodies. J. Biol. Chem. 282, 31803-31811.
10. Booth, M.J., Mistry, A., Li, X., Thrasher, A., and Coffin, R.S. (2004). Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids. Gene Ther. 11, 829-837.
11. Brown, C.S., Welling-Wester, S., Feijlbrief, M., Van Lent, J.W., and Spaan, W.J. (1994). Chimeric parvovirus B19 capsids for the presentation of foreign epitopes. Virology 198, 477-488.
12. Cao, L., Liu, Y., During, M.J., and Xiao, W. (2000). High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids. J. Virol. 74, 11456-11463.
13. Chahal, P.S., Aucoin, M.G., and Kamen, A. (2007). Primary recovery and chromatographic purification of adeno-associated virus type 2 produced by baculovirus/insect cell system. J. Virol. Methods 139, 61-70.
14. Clark, K.R., Voulgaropoulou, F., Fraley, D.M., and Johnson, P.R. (1995). Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther. 6, 1329-1341.
15. Clark, K.R., Voulgaropoulou, F., and Johnson, P.R. (1996). A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors. Gene Ther. 3, 1124-1132.
16. Conner, M.E., Zarley, C.D., Hu, B., Parsons, S., Drabinski, D., Greiner, S., Smith, R., Jiang, B., Corsaro, B., Barniak, V., Madore, H.P., Crawford, S., and Estes, M.K. (1996). Virus-like particles as a rotavirus subunit vaccine. J. Infect. Dis. 174(Suppl. 1), S88-S92.
17. Conway, J.E., Zolotukhin, S., Muzyczka, N., Hayward, G.S., and Byrne, B.J. (1997). Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap. J. Virol. 71, 8780-8789.
18. Conway, J.E., Rhys, C.M., Zolotukhin, I., Zolotukhin, S., Muzyczka, N., Hayward, G.S., and Byrne, B.J. (1999). High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. Gene Ther. 6, 986-993.
19. 7 cells per mL and production of β-galactosidase at high cell density by fed batch culture. Biotechnol. Bioeng. 68, 381-388.
20. Farson, D., Harding, T.C., Tao, L., Liu, J., Powell, S., Vimal, V., Yendluri, S., Koprivnikar, K., Ho, K., Twitty, C., Husak, P., Lin, A., Snyder, R.O., and Donahue, B.A. (2004). Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors. J. Gene Med. 6, 1369-1381.
21. Galarza, J.M., Latham, T., and Cupo, A. (2005). Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge. Viral Immunol. 18, 244-251.
22. Gorman, L., Suter, D., Emerick, V., Schumperli, D., and Kole, R. (1998). Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs. Proc. Natl. Acad. Sci. U.S.A. 95, 4929-4934.
23. Goyenvalle, A., Vulin, A., Fougerousse, F., Leturcq, F., Kaplan, J.C., Garcia, L., and Danos, O. (2004). Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science 306, 1796-1799.
24. Grimm, D., Kern, A., Rittner, K., and Kleinschmidt, J.A. (1998). Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum. Gene Ther. 9, 2745-2760.
25. Knop, D.R., and Harrell, H. (2007). Bioreactor production of recombinant herpes simplex virus vectors. Biotechnol. Prog. 23, 715-721.
26. Kohlbrenner, E., Aslanidi, G., Nash, K., Shklyaev, S., Campbell-Thompson, M., Byrne, B.J., Snyder, R.O., Muzyczka, N., Warrington, K.H., Jr., and Zolotukhin, S. (2005). Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system. Mol. Ther. 12, 1217-1225.
27. Li, H.H., Zhang, S.M., Fang, S.Y., Chen, C.L., Luo, Y.D., Guan, Y., Wang, D.W., and Xiao, X. (2003). [Adeno-associated virus vector carrying human minidystrophin gene SMCKA3999 effectively ameliorates dystrophic pathology in mdx model mice]. Zhonghua Yi Xue Za Zhi 83, 1513-1516.
28. Li, T.C., Yamakawa, Y., Suzuki, K., Tatsumi, M., Razak, M.A., Uchida, T., Takeda, N., and Miyamura, T. (1997). Expression and self-assembly of empty virus-like particles of hepatitis E virus. J. Virol. 71, 7207-7213.
29. Liu, X.L., Clark, K.R., and Johnson, P.R. (1999). Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus. Gene Ther. 6, 293-299.
30. Lopez de Turiso, J.A., Cortes, E., Martinez, C., Ruiz De Ybanez, R., Simarro, I., Vela, C., and Casal, I. (1992). Recombinant vaccine for canine parvovirus in dogs. J. Virol. 66, 2748-2753.
31. Mann, C.J., Honeyman, K., Cheng, A.J., Ly, T., Lloyd, F., Fletcher, S., Morgan, J.E., Partridge, T.A., and Wilton, S.D. (2001). Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proc. Natl. Acad. Sci. U.S.A. 98, 42-47.
32. Marcus, C.J., Laughlin, C.A., and Carter, B.J. (1981). Adeno-associated virus RNA transcription in vivo. Eur. J. Biochem. 121, 147-154.
33. Maxwell, F., Harrison, G.S., and Maxwell, I.H. (1997). Improved production of recombinant AAV by transient transfection of NB324K cells using electroporation. J. Virol. Methods 63, 129-136.
34. Modis, Y., Trus, B.L., and Harrison, S.C. (2002). Atomic model of the papillomavirus capsid. EMBO J. 21, 4754-4762.
35. Nakamura, S., Nakamura, R., Shibata, K., Kobayashi, M., Sahara, N., Shigeno, K., Shinjo, K., Naito, K., Ohnishi, K., Kasahara, N., and Iwaki, Y. (2004). Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary components. Eur. J. Haematol. 73, 285-294.
36. Negrete, A., and Kotin, R.M. (2007). Production of recombinant adeno-associated vectors using two bioreactor configurations at different scales. J. Virol. Methods 145, 155-161.
37. Negrete, A., and Kotin, R.M. (2008). Large-scale production of recombinant adeno-associated viral vectors. Methods Mol. Biol. 433, 79-96.
38. Negrete, A., Yang, L.C., Mendez, A.F., Levy, J.R., and Kotin, R.M. (2007). Economized large-scale production of high yield of rAAV for gene therapy applications exploiting baculovirus expression system. J. Gene Med. 9, 938-948.
39. Peabody, D.S. (1989). Translation initiation at non-AUG triplets in mammalian cells. J. Biol. Chem. 264, 5031-5035.
40. Ragot, T., Vincent, N., Chafey, P., Vigne, E., Gilgenkrantz, H., Couton, D., Cartaud, J., Briand, P., Kaplan, J.C., Perricaudet, M., and Kahn, A. (1993). Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647-650.
41. Redemann, B.E., Mendelson, E., and Carter, B.J. (1989). Adeno-associated virus Rep protein synthesis during productive infection. J. Virol. 63, 873-882.
42. Redmond, M.J., Ijaz, M.K., Parker, M.D., Sabara, M.I., Dent, D., Gibbons, E., and Babiuk, L.A. (1993). Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential. Vaccine 11, 273-281.
43. Renoux, V.M., Fleury, M.J., Bousarghin, L., Gaitan, J., Sizaret, P.Y., Touze, A., and Coursaget, P. (2008). Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice. Vaccine 26, 6602-6607.
44. Rosen, E., Stapleton, J.T., and McLinden, J. (1993). Synthesis of immunogenic hepatitis A virus particles by recombinant baculoviruses. Vaccine 11, 706-712.
45. Roy, P., French, T., and Erasmus, B.J. (1992). Protective efficacy of virus-like particles for bluetongue disease. Vaccine 10, 28-32.
46. Smith, G.E., Fraser, M.J., and Summers, M.D. (1983). Molecular engineering of the Autographa californica nuclear polyhedrosis virus genome: Deletion mutations within the polyhedrin gene. J. Virol. 46, 584-593.
47. Smith, R.H., Levy, J.R., and Kotin, R.M. (2009). A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells. Mol. Ther. doi:10.1038/mt.2009.128.
48. Stow, N.D. (1992). Herpes simplex virus type 1 origin-dependent DNA replication in insect cells using recombinant baculoviruses. J. Gen. Virol. 73, 313-321.
49. Suter, D., Tomasini, R., Reber, U., Gorman, L., Kole, R., and Schumperli, D. (1999). Double-target antisense U7 snRNAs promote efficient skipping of an aberrant exon in three human β-thalassemic mutations. Hum. Mol. Genet. 8, 2415-2423.
50. Urabe, M., Ding, C., and Kotin, R.M. (2002). Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum. Gene Ther. 13, 1935-1943.
51. Urabe, M., Nakakura, T., Xin, K.Q., Obara, Y., Mizukami, H., Kume, A., Kotin, R.M., and Ozawa, K. (2006). Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells. J. Virol. 80, 1874-1885.
52. van Deutekom, J.C., Bremmer-Bout, M., Janson, A.A., Ginjaar, I.B., Baas, F., den Dunnen, J.T., and van Ommen, G.J. (2001). Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum. Mol. Genet. 10, 1547-1554.
53. Wang, B., Li, J., and Xiao, X. (2000). Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc. Natl. Acad. Sci. U.S.A. 97, 13714-13719.
54. Watchko, J., O'Day, T., Wang, B., Zhou, L., Tang, Y., Li, J., and Xiao, X. (2002). Adeno-associated virus vector-mediated mini-dystrophin gene therapy improves dystrophic muscle contractile function in mdx mice. Hum. Gene Ther. 13, 1451-1460.
55. Wilton, S.D., Dye, D.E., and Laing, N.G. (1997). Dystrophin gene transcripts skipping the mdx mutation. Muscle Nerve 20, 728-734.
56. Wright, J.F. (2009). Transient transfection methods for clinical adeno-associated viral vector production. Hum. Gene Ther. 20, 698-706.
57. Xie, Q., Bu, W., Bhatia, S., Hare, J., Somasundaram, T., Azzi, A., and Chapman, M.S. (2002). The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 99, 10405-10410.
58. Yuasa, K., Yoshimura, M., Urasawa, N., Ohshima, S., Howell, J.M., Nakamura, A., Hijikata, T., Miyagoe-Suzuki, Y., and Takeda, S. (2007). Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products. Gene Ther. 14, 1249-1260.
59. Yue, Y., Li, Z., Harper, S.Q., Davisson, R.L., Chamberlain, J.S., and Duan, D. (2003). Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation 108, 1626-1632.
60. Zhang, X., De Alwis, M., Hart, S.L., Fitzke, F.W., Inglis, S.C., Boursnell, M.E., Levinsky, R.J., Kinnon, C., Ali, R.R., and Thrasher, A.J. (1999). High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H. Hum. Gene Ther. 10, 2527-2537.